Virus News and Research

Latest Virus News and Research

WHO investigates cases of H1N1 drug resistance in U.S., Britain

The WHO is looking into reports that patients with "severely suppressed immune systems" in Britain and the U.S. developed resistance Tamiflu, which is used to treat the symptoms of H1N1 (swine flu), a spokesman for the organization said Tuesday, Reuters reports.

25 Nov 2009

Given Imaging's PillCam SB wireless capsule endoscopy effective in treating GI patients

Given Imaging Ltd., the global leader in patient-friendly GI diagnostic and monitoring solutions, today announced that three new studies demonstrate that PillCam® SB endoscopy has a clear impact on how physicians manage GI patients, including those patients suspected of having Crohn's disease. The studies were presented at the Gastro 2009 conference taking place in London from November 21 to 25.

25 Nov 2009

Novartis to terminate its research collaboration agreement with Idera Pharmaceuticals

Idera Pharmaceuticals, Inc., today announced that Novartis will terminate its research collaboration agreement with the Company, effective as of February 21, 2010.

25 Nov 2009

Human Genome Sciences submits BLA for ZALBIN

Human Genome Sciences, Inc. today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ZALBIN™ (albinterferon alfa-2b) for the treatment of chronic hepatitis C. The BLA submission includes the results of two pivotal Phase 3 clinical trials showing that 900-mcg albinterferon alfa-2b dosed every two weeks met its primary endpoint of non-inferiority to peginterferon alfa-2a (Pegasys) dosed once each week.

25 Nov 2009

FDA provides marketing clearance for Prodesse's ProParaflu+ assay

Gen-Probe Incorporated announced today that the US Food and Drug Administration (FDA) has cleared for marketing Prodesse's ProParaflu+(TM) assay, a molecular test that detects and differentiates parainfluenza 1, 2 and 3 viruses, which cause lower respiratory tract infections.

25 Nov 2009

Pharmaceutical research and biotechnology companies test medicines and vaccines to treat HIV/AIDS

America's pharmaceutical research and biotechnology companies are testing 97 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).

25 Nov 2009

‘Testing Millions’ campaign in conjunction with World AIDS Day launched by AHF

As part of a groundbreaking global effort to test several million people for HIV in conjunction with this year’s observation of World AIDS Day on Tuesday, December 1st, AIDS Healthcare Foundation (AHF), the largest global AIDS organization, is spearheading and coordinating the ‘Testing Millions’ campaign. The campaign, which has been organized by AHF in coalition with hundreds of global partners from 52 countries around the world, is mobilizing non-governmental organizations (NGOs), local and national governments, international relief agencies, faith-based organizations and civil society to participate.

25 Nov 2009

Africa region leaders meet to discuss H1N1 procurement, distribution

Representatives of African countries are meeting in Abuja this week to discuss the procurement and distribution of the H1N1 (swine flu) vaccine, the Daily Trust/allAfrica.com reports (Rabiu, 11/23).

24 Nov 2009

Over 33m people worldwide living with HIV/AIDS, UNAIDS/WHO report finds

An estimated 33.4 million people worldwide are living with HIV/AIDS, according to a report released Tuesday in Shanghai by the WHO and UNAIDS that shows "more people are living longer due to the availability of drugs," Reuters/Washington Post reports (Rujun/Chan, 11/24).

24 Nov 2009

Gilead Sciences and GSK to commercialize Viread in 5 Asian countries

Gilead Sciences, Inc. and GlaxoSmithKline today announced a licensing agreement to commercialize Viread® (tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B (HBV) infection in adults in five countries in Asia. The companies’ combined commercialization activities will expand access to Viread for the treatment of HBV, once approved, to patients in Asia where the prevalence in most countries is greater than 8 percent.

24 Nov 2009

Studies demonstrate clinical utility of Given Imaging's PillCam SB capsule endoscopy

Given Imaging Ltd., the global leader in patient-friendly GI diagnostic and monitoring solutions, today announced three new studies that demonstrate the clinical utility of PillCam SB capsule endoscopy in providing physicians with critical information on how they manage and/or diagnose intestinal disorders. These novel studies were carried out in pediatric patients with gastrointestinal symptoms, including children with known or suspected Crohn's disease.

24 Nov 2009

Fourth-quarter and year-end fiscal 2009 results announced by Allied Healthcare International

Allied Healthcare International Inc., a leading provider of flexible healthcare staffing services in the United Kingdom, has issued financial results for its fiscal 2009 fourth quarter and year-end.

24 Nov 2009

Americans with hepatitis C are at increased risk of developing liver cancer, says NVHR

New peer-reviewed data finding that fewer than one-fifth of the nearly 4 million Americans infected with chronic hepatitis C virus have received anti-viral therapy in recent years should be a wake-up call that Congress needs to move urgently on bipartisan legislation to support new state-based detection, research, and surveillance efforts, the National Viral Hepatitis Roundtable (NVHR) said today.

24 Nov 2009

Iowa State University's researcher develops and ships H1N1 vaccine for swine producers

The only swine vaccine available for the H1N1 virus has been sent to vaccinate a swine herd infected with the virus. The vaccination marks the first time vaccine has been sent to a swine herd diagnosed with the pandemic flu.

24 Nov 2009

Treatment rates for hepatitis C virus declining, say researchers

Researchers from the University of Michigan determined that only 663,000 of the approximately 3.9 million Americans with hepatitis C virus (HCV) infection received antiviral therapy between 2002 and 2007.

24 Nov 2009

Jubilant Organosys, UAB and Southern Research Institute announce joint venture to accelerate global drug development

Jubilant Organosys, the University of Alabama at Birmingham (UAB), and Southern Research Institute today announced a joint venture that will focus on leveraging their collective innovation and enabling technologies in the areas of Oncology, Metabolic Disease and Infectious Diseases. It is a unique U.S.-India arbitraged and leveraged partnership that will accelerate the development of affordable therapies for patients worldwide.

24 Nov 2009

Antiviral therapy for hepatitis C appears to be declining in the U.S.; lack of diagnosis is primary barrier to treatment

23 Nov 2009

H1N1 spreading eastward, WHO says

The H1N1 (swine flu) virus appears to be spreading eastward across Europe and Asia, after appearing to have leveled off in the U.S. and some western European countries, the WHO said Friday, Reuters reports.

23 Nov 2009

Guardian examines challenge of testing, treating patients with HIV/AIDS in Kenya

The Guardian examines the challenge of testing and treating some of the estimated 1.4 million people living with HIV/AIDS in Kenya. "Deep-rooted stigma and patchy health education has led many to cower from the disease, which has seen the country's life expectancy rates shortened by 20 years in the last two decades," the newspaper writes. Even though "[t]he country's government has supplied antiretroviral therapy (ART) to suppress the virus to patients for free since 2006, … of the 390,000 adults estimated as being eligible for ART at the time of the survey, around 140,000, or 35%, were taking the medication," according to a 2007 country survey.

23 Nov 2009

New FluCide better than the older version

NanoViricides, Inc., announced today that Dr. Eugene Seymour, MD MPH, CEO of the Company, presented lifetime data from the recent FluCide™ animal study on November 19th at the Influenza Congress USA 2009 in Washington, DC (www.terrapinn.com/usaflu). These data clearly established that the new version of FluCide™ is superior to the older version.

23 Nov 2009

Virus News and Research

Latest Virus News and Research

WHO investigates cases of H1N1 drug resistance in U.S., Britain

Given Imaging's PillCam SB wireless capsule endoscopy effective in treating GI patients

Novartis to terminate its research collaboration agreement with Idera Pharmaceuticals

Human Genome Sciences submits BLA for ZALBIN

FDA provides marketing clearance for Prodesse's ProParaflu+ assay

Pharmaceutical research and biotechnology companies test medicines and vaccines to treat HIV/AIDS

‘Testing Millions’ campaign in conjunction with World AIDS Day launched by AHF

Africa region leaders meet to discuss H1N1 procurement, distribution

Over 33m people worldwide living with HIV/AIDS, UNAIDS/WHO report finds

Gilead Sciences and GSK to commercialize Viread in 5 Asian countries

Studies demonstrate clinical utility of Given Imaging's PillCam SB capsule endoscopy

Fourth-quarter and year-end fiscal 2009 results announced by Allied Healthcare International

Americans with hepatitis C are at increased risk of developing liver cancer, says NVHR

Iowa State University's researcher develops and ships H1N1 vaccine for swine producers

Treatment rates for hepatitis C virus declining, say researchers

Jubilant Organosys, UAB and Southern Research Institute announce joint venture to accelerate global drug development

Antiviral therapy for hepatitis C appears to be declining in the U.S.; lack of diagnosis is primary barrier to treatment

H1N1 spreading eastward, WHO says

Guardian examines challenge of testing, treating patients with HIV/AIDS in Kenya

New FluCide better than the older version

A new way of characterising biomolecules eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in